Ellen Rohde
Corporate Officer/Principal presso VERVE THERAPEUTICS, INC.
Posizioni attive di Ellen Rohde
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2019 | - |
Storia della carriera di Ellen Rohde
Precedenti posizioni note di Ellen Rohde
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
| BIOGEN INC. | Corporate Officer/Principal | - | - |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formazione di Ellen Rohde
| University of Cincinnati (Ohio) | Doctorate Degree |
| Universität Leipzig | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Ellen Rohde
- Esperienza
